TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course.
about
Nutritional supplements for people being treated for active tuberculosisVitamin D as Adjunctive Host-Directed Therapy in Tuberculosis: A Systematic ReviewPersisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cureThe Bandim TBscore--reliability, further development, and evaluation of potential uses.Clinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis.Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study.Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatmentLow nutrient intake among adult women and patients with severe tuberculosis disease in Uganda: a cross-sectional study.Illness perception in tuberculosis by implementation of the Brief Illness Perception Questionnaire - a TBNET study.Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with puInduced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.A Clinical Scoring Algorithm for Determination of the Risk of Tuberculosis in HIV-Infected Adults: A Cohort Study Performed at Ethiopian Health Centers.Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary TuberculosisPsychological distress and its relationship with non-adherence to TB treatment: a multicentre study.Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.Asymptomatic Helminth Infection in Active Tuberculosis Is Associated with Increased Regulatory and Th-2 Responses and a Lower Sputum Smear PositivitySignificant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial.A Prediction Rule to Stratify Mortality Risk of Patients with Pulmonary Tuberculosis.Prevalence and clinical relevance of helminth co-infections among tuberculosis patients in urban Tanzania.A predictive scoring instrument for tuberculosis lost to follow-up outcome.Host gene-encoded severe lung TB: from genes to the potential pathwaysVitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention studyAdjuvant Efficacy of Nutrition Support During Pulmonary Tuberculosis Treating Course: Systematic Review and Meta-analysisXpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?An automated tuberculosis screening strategy combining X-ray-based computer-aided detection and clinical information.Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.Tuberculosis incidence in elderly in Serbia: key trends in socioeconomic transitionTuberculosis assays: past, present and future.Transcultural Adaptation and Validation of the Korean Version of the Brief Illness Perception Questionnaire for Patients with Pulmonary Tuberculosis.Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.TBscore II: refining and validating a simple clinical score for treatment monitoring of patients with pulmonary tuberculosis.Inter-observer variation of the Bandim TB-score.Early treatment response evaluated by a clinical scoring system correlates with the prognosis of pulmonary tuberculosis patients in Ethiopia: a prospective follow-up study.False positive Xpert MTB/RIF results in re-tested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes.Prognostic indicators in the World Health Organization's algorithm for seriously ill HIV-infected inpatients with suspected tuberculosis.The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients - protocol for a double-blind, placebo-controlled randomised trial.The Bandim tuberculosis score: reliability and comparison with the Karnofsky performance score.Impact of nicotine replacement therapy as an adjunct to anti-tuberculosis treatment and behaviour change counselling in newly diagnosed pulmonary tuberculosis patients: an open-label, randomised controlled trial.Anemia in tuberculosis cases and household controls from Tanzania: Contribution of disease, coinfections, and the role of hepcidin.
P2860
Q26471390-2143D97C-8DFB-42E6-8E68-E96BC7ADEEB4Q28071387-89366A09-F685-4676-9CF4-026383CB842CQ28391110-584EEDC7-A94D-49D4-8EC6-BD03B9612909Q33655933-82F68CF5-CF7A-4B8C-BFF6-523B67EFD3A1Q33658873-4E9A2924-2552-4323-9DC5-D4A9B4EBA1C1Q33795863-12201EAD-C320-458B-8739-7D6B9B1BCFD5Q34399577-DED9487E-B237-42E9-8546-D864D51D5216Q34502970-97386A39-A3C0-4588-B00B-E3123C881D7AQ34517280-EAA51F28-5DC6-4F79-83BB-B2EB7A2BAB80Q34554105-FCCB18E8-CF3D-468E-B184-C21C0545EE48Q34684277-9D32683B-16C1-4315-8E67-4ACCEF355EE8Q34932689-2C816E19-AC1E-430B-B069-08E126FC4DF9Q35072083-00474ABF-8803-4FBF-BD3C-6C296C5A4679Q35634195-D5AA1FE4-FF72-474F-ABDD-47FC5C0DC1F8Q35678962-76BBB972-CD4A-4853-8578-CE71192816F9Q35686427-093F90D1-669A-45B6-A203-1658359D8349Q35738977-A6341727-5B05-43F4-8C59-96FBBA03F3D0Q35783492-190B9BAE-AC9F-4896-AC33-55EC0AC110FBQ36135526-FAC88950-3DB9-4A21-A3B2-94902A9504ACQ36274227-AF7203E8-E108-4B9B-BE95-930D46636800Q36376863-2182902F-6AD7-4EFF-ACE5-B765947194B1Q36457279-BDB0F427-9C6D-49B5-937C-D0A8B12D9380Q36496314-17356466-DDD2-4FD3-AAC6-7E2BBE1E0927Q36694647-D16D5364-8847-4F25-9FF5-72755B9E7240Q36715814-665CBA3A-94D0-4DF9-82E2-ED582E6122F9Q36850517-F1DDA731-E8B0-41CE-8CE0-7DBD43BAB465Q36957252-841AA5A4-626D-4130-AFFE-7B436144A364Q37051933-59705EA6-186A-424C-BA14-D9F77BC8A224Q37866817-FC914287-1105-4A1A-B13A-77A1D0BC078AQ41525075-CCBF3E96-9B3E-409F-B291-AB5A3710F649Q42715629-52352BDF-D460-452B-8F8B-C896B34DB010Q44658741-8C6CE207-AEFC-44FC-AF87-4878D79B6647Q45341481-E5998997-71BC-4A81-B272-E19867A8086DQ46445072-F0D24877-C546-46C8-AD1B-04888924FBC4Q47203491-BC7E285E-ABF2-495E-8AB3-AEBFC43E2AB1Q49243354-4E72377F-F905-47F5-B1AF-9BC57A7C6E62Q52574704-DC21653A-42C5-4239-A1F1-85236C5331BFQ53108706-AE3CC35E-A725-4751-B86A-4961DE0EF68BQ55405141-0B34510F-DBA2-4888-9C66-393D776D30AEQ55462983-BABC4765-6CA6-4AA9-BB99-15CDE5CDF528
P2860
TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
TBscore: Signs and symptoms fr ...... sed to assess clinical course.
@en
type
label
TBscore: Signs and symptoms fr ...... sed to assess clinical course.
@en
prefLabel
TBscore: Signs and symptoms fr ...... sed to assess clinical course.
@en
P2093
P2860
P50
P1476
TBscore: Signs and symptoms fr ...... used to assess clinical course
@en
P2093
Jens Nielsen
Paul Lehm Andersen
Per Gustafson
Victor Francisco Gomes
P2860
P304
P356
10.1080/00365540701558698
P577
2008-01-01T00:00:00Z